Jensen Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$57.2M |
| 2 |
Medtronic
MDT
|
+$5.26M |
| 3 |
PX
Praxair Inc
PX
|
+$5.02M |
| 4 |
Becton Dickinson
BDX
|
+$1.61M |
| 5 |
Usana Health Sciences
USNA
|
+$503K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$123M |
| 2 |
Nike
NKE
|
+$74M |
| 3 |
Colgate-Palmolive
CL
|
+$46.5M |
| 4 |
Amphenol
APH
|
+$40.7M |
| 5 |
PepsiCo
PEP
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.68% |
| 2 | Industrials | 20.9% |
| 3 | Consumer Staples | 17.26% |
| 4 | Healthcare | 13.08% |
| 5 | Materials | 11.1% |
Similar funds
Jensen Investment Management's Q2 2014 Portfolio in Review
As of Q2 2014, Jensen Investment Management held 100 positions worth $6.64B, down 4.3% from $6.94B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Jensen Investment Management withdrew a net $405M in Q2 2014, closing 7 positions and reducing 63 holdings. Its most notable exit was Lexmark Intl Inc, an estimated $579K position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Jensen Investment Management opened a new position in Usana Health Sciences worth $530K.
- Jensen Investment Management's largest Q2 2014 buy was Usana Health Sciences: 13,560 shares worth $530K.
- Jensen Investment Management added most to TJX Companies in Q2 2014, an estimated $57.2M increase.
- Jensen Investment Management's biggest Q2 2014 reduction was Abbott, cutting an estimated $123M.
- Jensen Investment Management fully exited Lexmark Intl Inc in Q2 2014, selling an estimated $579K.
- Jensen Investment Management's ten largest holdings make up 49% of its $6.64B portfolio in Q2 2014.
- Jensen Investment Management opened 17 new positions and closed 7 in Q2 2014.
- Jensen Investment Management's portfolio value fell 4.3% quarter-over-quarter to $6.64B.
Based on Jensen Investment Management's 13F filing for Q2 2014, filed 25 Jul 2014.